Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib. (Q54618926)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib. |
scientific article |
Statements
Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib. (English)
1 reference
1 reference
William Pao
1 reference
Yelena Y Janjigian
1 reference
Christopher G Azzoli
1 reference
Lee M Krug
1 reference
Leanne K Pereira
1 reference
Naiyer A Rizvi
1 reference
M Catherine Pietanza
1 reference
Michelle S Ginsberg
1 reference
Vincent A Miller
1 reference
Gregory J Riely
1 reference
19 January 2011
1 reference
17
1 reference
8
1 reference
2521-2527
1 reference
Identifiers
1 reference